.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022114

« Back to Dashboard
NDA 022114 describes ZINGO, which is a drug marketed by Powder Pharms and is included in one NDA. It is available from three suppliers. There are six patents protecting this drug. Additional details are available on the ZINGO profile page.

The generic ingredient in ZINGO is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for NDA: 022114

Tradename:
ZINGO
Applicant:
Powder Pharms
Ingredient:
lidocaine hydrochloride
Patents:6
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 022114

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 022114

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL 022114 NDA Medline Industries, Inc. 53329-200 53329-200-57 12 POUCH in 1 CARTON (53329-200-57) > 1 POWDER in 1 POUCH
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL 022114 NDA Powder Pharmaceuticals Inc. 61388-001 61388-001-48 12 POUCH in 1 CARTON (61388-001-48) > 1 POWDER in 1 POUCH

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYSTEM;INTRADERMALStrength0.5MG
Approval Date:Aug 16, 2007TE:RLD:No
Patent:5,899,880Patent Expiration:May 4, 2016Product Flag?YSubstance Flag?Delist Request?
Patent:6,004,286Patent Expiration:Mar 17, 2017Product Flag?YSubstance Flag?Delist Request?
Patent:6,881,200Patent Expiration:Jun 11, 2016Product Flag?YSubstance Flag?Delist Request?

Expired Orange Book Patents for NDA: 022114

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 20075,630,796► subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 20076,881,200► subscribe
Powder Pharms
ZINGO
lidocaine hydrochloride
SYSTEM;INTRADERMAL022114-001Aug 16, 20075,899,880► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc